The role of glucagon‐like peptide‐1 impairment in obesity and potential therapeutic implications
Year: 2013
Type: review
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.12119
Author: S. Madsbad
Institution: Hvidovre Hospital
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Novo Nordisk
OpenAlex ID: W1988527243
